Skip to main content
OUR COMPANY
Mission & strategy
Leadership
Partnering
Contact us
Compliance
OUR SCIENCE
Pipeline
Tovorafenib
DAY301
Clinical trials
Expanded access
Publications & posters
Investigator-sponsored research
OUR MEDICINE
OJEMDA™ (tovorafenib)
PATIENTS
Overview
Patient stories
Our advocacy team
Resources
Community news
CAREERS
Overview
Open positions
Benefits
Inclusion & belonging
Culture
MEDIA & INVESTORS
Overview
News & events
Stock information
Financial information
Corporate governance
Investor resources
×
You are now leaving the Day One Biopharmaceuticals Corporate Website
You will now be redirected to the requested website. Please confirm that you want to proceed.
Yes
No